FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Demeclocycline Hydrochloride Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Expand all

Teva Pharmaceuticals (New 04/21/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
150 mg 100 count (NDC 0555-0701-02) 04/21/2020 Teva had evaluated the market and decided to discontinue the product.
300 mg 48 count (NDC 0555-0702-84) 04/21/2020 Teva had evaluated the market and decided to discontinue the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English